Cargando…

Beyond the Glycaemic Control of Dapagliflozin: Impact on Arterial Stiffness and Macroangiopathy

Dapagliflozin is a selective sodium–glucose cotransporter 2 inhibitor (SGLT2i) indicated for the treatment of type 2 diabetes mellitus (T2DM), heart failure with reduced ejection fraction and chronic kidney disease. In all indications, treatment can be initiated in adults with estimated glomerular f...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-Clemente, José M., García-Castillo, María, Gorgojo-Martínez, Juan J., Jiménez, Alberto, Llorente, Ignacio, Matute, Eduardo, Tejera, Cristina, Izarra, Aitziber, Lecube, Albert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240142/ https://www.ncbi.nlm.nih.gov/pubmed/35687260 http://dx.doi.org/10.1007/s13300-022-01280-6

Ejemplares similares

Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications
por: Bellido, Virginia, et al.
Publicado: (2022)

Selenoprotein S: a therapeutic target for diabetes and macroangiopathy?
por: Yu, Shan-shan, et al.
Publicado: (2017)

MELAS and macroangiopathy: A case report and literature review
por: Sun, Xiangrong, et al.
Publicado: (2018)

Macroangiopathy is a positive predictive factor for response to immunotherapy
por: Deike-Hofmann, Katerina, et al.
Publicado: (2019)

Characterization of lncRNA and mRNA profiles in rats with diabetic macroangiopathy
por: Yang, Chan, et al.
Publicado: (2020)

Serum vitamin K(1) associated to microangiopathy and/or macroangiopathy in individuals with and without diabetes
por: Bøgh Andersen, Ida, et al.
Publicado: (2020)

Association of Serum Adiponectin with Intima Media Thickness of Dorsalis Pedis Artery and Macroangiopathy in Type 2 Diabetes
por: Chen, Tao, et al.
Publicado: (2020)

Dapagliflozin plus exenatide on patients with type 2 diabetes awaiting bariatric surgery in the DEXBASU study
por: López-Cano, Carolina, et al.
Publicado: (2022)

Associations of Renal Vascular Resistance With Albuminuria and Other Macroangiopathy in Type 2 Diabetic Patients
por: Hamano, Kumiko, et al.
Publicado: (2008)

Aldose reductase gene is associated with diabetic macroangiopathy in Japanese Type 2 diabetic patients
por: Watarai, A, et al.
Publicado: (2006)

The Effect of Chromium Picolinate Supplementation on the Pancreas and Macroangiopathy in Type II Diabetes Mellitus Rats
por: Huang, Shan, et al.
Publicado: (2014)

Mild anemia is frequent and associated with micro‐ and macroangiopathies in patients with type 2 diabetes mellitus
por: Ito, Hiroyuki, et al.
Publicado: (2010)

The effect of haptoglobin genotype on the association of asymmetric dimethylarginine and DDAH 1 polymorphism with diabetic macroangiopathy
por: Wang, Shiyun, et al.
Publicado: (2022)

Comment on “The Effect of Chromium Picolinate Supplementation on the Pancreas and Macroangiopathy in Type II Diabetes Mellitus Rats”
por: Verma, Hitesh, et al.
Publicado: (2015)

The association between paraoxonase 1 activity and the susceptibilities of diabetes mellitus, diabetic macroangiopathy and diabetic microangiopathy
por: Wu, Diling, et al.
Publicado: (2018)

Radix pseudostellariae of Danzhi Jiangtang capsule relieves oxidative stress of vascular endothelium in diabetic macroangiopathy
por: Fang, Zhaohui, et al.
Publicado: (2020)

Sodium-glucose cotransporter inhibitors: beyond glycaemic control
por: Vergara, Ander, et al.
Publicado: (2019)

Efficacy and safety of shenqi compound for the treatment of diabetic macroangiopathy: A protocol for systematic review and meta-analysis
por: Hu, Zhipeng, et al.
Publicado: (2020)

Profilin-1 is involved in macroangiopathy induced by advanced glycation end products via vascular remodeling and inflammation
por: Xiao, Zhi-Lin, et al.
Publicado: (2021)

Investigation of the Effects and Mechanisms of Mai Tong Formula on Lower Limb Macroangiopathy in a Spontaneous Diabetic Rat Model
por: Gong, Guangming, et al.
Publicado: (2016)

Mendelian randomization analysis to assess a causal effect of haptoglobin on macroangiopathy in Chinese type 2 diabetes patients
por: Wang, Shiyun, et al.
Publicado: (2018)

The Association of Cardio-Ankle Vascular Index and Ankle-Brachial Index with Macroangiopathy in Patients with Type 2 Diabetes Mellitus
por: Niwa, Hirokatsu, et al.
Publicado: (2019)

Serum levels of mac-2 binding protein are associated with diabetic microangiopathy and macroangiopathy in people with type 2 diabetes
por: Hashimoto, Yoshitaka, et al.
Publicado: (2020)

Relationship Between the Triglyceride-Glucose Index and Type 2 Diabetic Macroangiopathy: A Single-Center Retrospective Analysis
por: Yao, Haipeng, et al.
Publicado: (2022)

Protocol for a randomised controlled trial of the effect of dapagliflozin, metformin and exercise on glycaemic variability, body composition and cardiovascular risk in prediabetes (the PRE-D Trial)
por: Færch, Kristine, et al.
Publicado: (2017)

Durability of glycaemic control with dapagliflozin, an SGLT2 inhibitor, compared with saxagliptin, a DPP4 inhibitor, in patients with inadequately controlled type 2 diabetes
por: Bailey, Clifford J., et al.
Publicado: (2019)

A Comparison of the Pharmacokinetics and Safety of Dapagliflozin Formate, an Ester Prodrug of Dapagliflozin, to Dapagliflozin Propanediol Monohydrate in Healthy Subjects
por: Kim, Hyun Chul, et al.
Publicado: (2023)

Peripheral Sensory Neuropathy Associates With Micro- or Macroangiopathy: Results from a population-based study of type 2 diabetic patients in Sweden
por: Kärvestedt, Lars, et al.
Publicado: (2009)

Effect of Empagliflozin and Dapagliflozin on Ambulatory Arterial Stiffness in Patients with Type 2 Diabetes Mellitus and Cardiovascular Co-Morbidities: A Prospective, Observational Study
por: Patoulias, Dimitrios, et al.
Publicado: (2022)

Arterial Stiffness
por: Avolio, Alberto
Publicado: (2013)

Characteristics of Dapagliflozin Responders: A Longitudinal, Prospective, Nationwide Dapagliflozin Surveillance Study in Korea
por: Han, Eugene, et al.
Publicado: (2018)

Primary Prevention of Macroangiopathy in Patients With Short-Duration Type 2 Diabetes by Intensified Multifactorial Intervention: Seven-year follow-up of diabetes complications in Chinese
por: Yang, Yu, et al.
Publicado: (2013)

Stiff isotropic lattices beyond the Maxwell criterion
por: Chen, Wen, et al.
Publicado: (2019)

Arterial Stiffness in Type 1 Diabetes: The Case for the Arterial Wall Itself as a Target Organ
por: González-Clemente, José-Miguel, et al.
Publicado: (2021)

Not so critical appraisal of dapagliflozin
por: Doggrell, Sheila A
Publicado: (2014)

Dietary glycaemic index and glycaemic load in relation to risk of breast cancer
por: Rigi, Somaye, et al.
Publicado: (2022)

Arterial Stiffness and Adult Onset Vasculitis: A Systematic Review
por: Lo Gullo, Alberto, et al.
Publicado: (2022)

Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension
por: Tang, Yi, et al.
Publicado: (2022)

The Associations between Paraoxonase 1 L55M/Q192R Genetic Polymorphisms and the Susceptibilities of Diabetic Macroangiopathy and Diabetic Microangiopathy: A Meta-Analysis
por: Wu, Chenfang, et al.
Publicado: (2018)

Cardiovascular magnetic resonance measures of aortic stiffness in asymptomatic patients with type 2 diabetes: association with glycaemic control and clinical outcomes
por: Swoboda, Peter P., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gf457vp2mv6m34a28l2po5j2ab